Literature DB >> 7684195

Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.

A J Rozemuller1, R A Roos, G T Bots, W Kamphorst, P Eikelenboom, W E Van Nostrand.   

Abstract

Brain amyloidosis with abundant beta/A4 protein deposition in plaques and cortical and meningeal vessels is found in Alzheimer's disease (AD) and hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D). In contrast to AD, no neuritic pathology or classical congophilic plaques are found in HCHWA-D. Unlike most AD cases, the congophilic angiopathy in HCHWA-D is very severe. It is still unknown whether beta/A4 deposits in plaques and vessels have the same origin. In this study, we have used frozen cortical tissue of HCHWA-D and AD patients to investigate the beta/A4 amyloid protein and the amyloid precursor protein (APP) in different types of plaques and congophilic angiopathy. Immunohistochemical staining was conducted using antibodies against synthetic beta/A4 proteins and antibodies against APP including MAbP2-1, a monoclonal antibody against purified protease nexin-2, which is the secreted form of APP. In contrast to immunohistochemical studies on formalin-fixed, paraffin-embedded tissue, frozen tissue of HCHWA-D patients revealed a very high number of beta/A4 plaques resembling AD. All plaques were of the diffuse type. Double-staining with MabP2-1 and beta/A4 antisera revealed: 1) the presence of APP immunoreactivity in classical plaques and transitional forms; 2) the absence of APP immunoreactivity in diffuse plaques in HCHWA-D and AD; and 3) pronounced APP immunoreactivity in congophilic vessels in HCHWA-D in contrast to weak APP staining in congophilic vessels in AD. Together these findings suggest that: a) the presence of APP in plaques is related to neuritic changes; b) different processes occur in amyloid formation in plaques and vessels; and c) differences exist between the process of amyloid formation in HCHWA-D and AD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684195      PMCID: PMC1886931     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

1.  Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing.

Authors:  S S Sisodia; E H Koo; K Beyreuther; A Unterbeck; D L Price
Journal:  Science       Date:  1990-04-27       Impact factor: 47.728

2.  Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains.

Authors:  S Ikeda; N Yanagisawa; D Allsop; G G Glenner
Journal:  Lab Invest       Date:  1989-07       Impact factor: 5.662

3.  Alzheimer's disease: mismatch between amyloid plaques and neuritic plaques.

Authors:  H Braak; E Braak; T Ohm; J Bohl
Journal:  Neurosci Lett       Date:  1989-08-14       Impact factor: 3.046

4.  Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease.

Authors:  K Ogomori; T Kitamoto; J Tateishi; Y Sato; M Suetsugu; M Abe
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

5.  Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor.

Authors:  W E Van Nostrand; S L Wagner; M Suzuki; B H Choi; J S Farrow; J W Geddes; C W Cotman; D D Cunningham
Journal:  Nature       Date:  1989-10-12       Impact factor: 49.962

6.  Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques.

Authors:  H Arai; V M Lee; L Otvos; B D Greenberg; D E Lowery; S K Sharma; M L Schmidt; J Q Trojanowski
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

Review 7.  Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease.

Authors:  D J Selkoe
Journal:  Neurobiol Aging       Date:  1989 Sep-Oct       Impact factor: 4.673

8.  Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals.

Authors:  F Tagliavini; G Giaccone; B Frangione; O Bugiani
Journal:  Neurosci Lett       Date:  1988-11-11       Impact factor: 3.046

9.  The immunohistochemical demonstration of subsequences of the precursor of the amyloid A4 protein in senile plaques in Alzheimer's disease.

Authors:  T Ishii; F Kametani; S Haga; M Sato
Journal:  Neuropathol Appl Neurobiol       Date:  1989 Mar-Apr       Impact factor: 8.090

10.  Familial cerebral amyloid angiopathy presenting as recurrent cerebral haemorrhage.

Authors:  A R Wattendorff; G T Bots; L N Went; L J Endtz
Journal:  J Neurol Sci       Date:  1982-08       Impact factor: 3.181

View more
  20 in total

1.  Protease nexin-2/amyloid beta-protein precursor limits cerebral thrombosis.

Authors:  Feng Xu; Judianne Davis; Jianting Miao; Mary Lou Previti; Galina Romanov; Kelly Ziegler; William E Van Nostrand
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

2.  The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease.

Authors:  E Kövari; F R Herrmann; P R Hof; C Bouras
Journal:  Neuropathol Appl Neurobiol       Date:  2013-08       Impact factor: 8.090

Review 3.  The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis.

Authors:  William E Van Nostrand
Journal:  Biochim Biophys Acta       Date:  2015-10-27

4.  Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein.

Authors:  Jianting Miao; Feng Xu; Judianne Davis; Irene Otte-Höller; Marcel M Verbeek; William E Van Nostrand
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

5.  Distribution of neuronal growth-promoting factors and cytoskeletal proteins in altered neurites in Alzheimer's disease and non-demented elderly.

Authors:  S S Zhan; W Kamphorst; W E Van Nostrand; P Eikelenboom
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 6.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 7.  Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease.

Authors:  Elena Anahi Bignante; Florencia Heredia; Gerardo Morfini; Alfredo Lorenzo
Journal:  Neurobiol Aging       Date:  2013-05-25       Impact factor: 4.673

Review 8.  Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.

Authors:  S Hunter; C Brayne
Journal:  Mol Psychiatry       Date:  2017-11-07       Impact factor: 15.992

9.  Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa.

Authors:  A H Schmaier; L D Dahl; A J Rozemuller; R A Roos; S L Wagner; R Chung; W E Van Nostrand
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  AbetaPP/APLP2 family of Kunitz serine proteinase inhibitors regulate cerebral thrombosis.

Authors:  Feng Xu; Mary Lou Previti; Marvin T Nieman; Judianne Davis; Alvin H Schmaier; William E Van Nostrand
Journal:  J Neurosci       Date:  2009-04-29       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.